The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 17, Pages 6401
Publisher
MDPI AG
Online
2020-09-03
DOI
10.3390/ijms21176401
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of interleukins 17A and 17F in psoriatic arthritis
- (2020) Peter Nash LANCET
- Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
- (2020) Christopher T Ritchlin et al. LANCET
- Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)
- (2020) Vinod Chandran et al. RHEUMATOLOGY
- Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
- (2020) Désirée van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Philip J Mease et al. LANCET
- Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Atul Deodhar et al. LANCET
- Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial
- (2020) Iain B McInnes et al. LANCET
- IL-23 inhibitor guselkumab shows promise for PsA
- (2020) Jessica McHugh Nature Reviews Rheumatology
- Fab Fragment of VHH-Based Antibody Netakimab: Crystal Structure and Modeling Interaction with Cytokine IL-17A
- (2019) Olga Kostareva et al. Crystals
- Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression
- (2019) Richard James Cuthbert et al. ANNALS OF THE RHEUMATIC DISEASES
- A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
- (2019) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ixekizumab or secukinumab in psoriasis: what difference does it make?
- (2018) C. Paul BRITISH JOURNAL OF DERMATOLOGY
- Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab
- (2018) R.B. Warren et al. BRITISH JOURNAL OF DERMATOLOGY
- Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic Arthritis
- (2018) Alina Soare et al. JOURNAL OF IMMUNOLOGY
- Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
- (2018) Mark G. Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IL-17 in the immunopathogenesis of spondyloarthritis
- (2018) Leonie S. Taams et al. Nature Reviews Rheumatology
- Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis
- (2018) Mark C Genovese et al. RHEUMATOLOGY
- Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response
- (2018) Philip J. Mease et al. Arthritis & Rheumatology
- Increased IL-22- and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis
- (2018) Éric Toussirot et al. Frontiers in Immunology
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
- (2018) Ellen M. Gravallese et al. Nature Reviews Rheumatology
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
- (2018) Atul Deodhar et al. Arthritis & Rheumatology
- Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis
- (2018) Daniel Wendling et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
- (2018) Désirée van der Heijde et al. LANCET
- Enthesitis: from pathophysiology to treatment
- (2017) Georg Schett et al. Nature Reviews Rheumatology
- Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
- (2017) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis
- (2017) M. H. Al-Mossawi et al. Nature Communications
- Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis
- (2017) Richard J. Cuthbert et al. Arthritis & Rheumatology
- Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
- (2016) Jürgen Braun et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis
- (2016) Eric Gracey et al. ANNALS OF THE RHEUMATIC DISEASES
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
- (2016) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients
- (2016) G. Guggino et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis
- (2016) E. Hayashi et al. JOURNAL OF RHEUMATOLOGY
- Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
- (2016) David Ellinghaus et al. NATURE GENETICS
- Ankylosing Spondylitis and Axial Spondyloarthritis
- (2016) Joel D. Taurog et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis
- (2015) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial
- (2015) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
- (2015) Michele W L Teng et al. NATURE MEDICINE
- The IL-23–IL-17 axis in inflammatory arthritis
- (2015) Erik Lubberts Nature Reviews Rheumatology
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases
- (2015) Jose U. Scher et al. Arthritis & Rheumatology
- Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis
- (2015) Mary-Ellen Costello et al. Arthritis & Rheumatology
- FRI0303 Discovery and Characterization of Abt-122, an Anti-TNF/IL-17 Dvd-Ig™ Molecule as A Potential Therapeutic Candidate for Rheumatoid Arthritis
- (2014) C.-M. Hsieh et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of mechanical stress in the pathogenesis of spondyloarthritis and how to combat it
- (2014) Peggy Jacques et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- IL-17A Produced by T Cells Plays a Critical Role in Innate Immunity against Listeria monocytogenes Infection in the Liver
- (2014) S. Hamada et al. JOURNAL OF IMMUNOLOGY
- The IL-17A-Producing CD8 + T-Cell Population in Psoriatic Lesional Skin Comprises Mucosa-Associated Invariant T Cells and Conventional T Cells
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis
- (2014) CHENGGONG WANG et al. Experimental and Therapeutic Medicine
- Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease
- (2014) Jose U. Scher et al. Arthritis & Rheumatology
- Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
- (2014) Bina Menon et al. Arthritis & Rheumatology
- Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort
- (2013) Liesbet Van Praet et al. ANNALS OF THE RHEUMATIC DISEASES
- Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells
- (2013) Peggy Jacques et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Th17 and Th22 cells in psoriatic arthritis and psoriasis
- (2013) Helen Benham et al. ARTHRITIS RESEARCH & THERAPY
- HLA-B27 frequency in a group of patients with psoriatic arthritis
- (2012) Danilo Garcia Ruiz et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model
- (2012) Liesbet Van Praet et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17-producing γδ T cells and innate lymphoid cells
- (2012) Caroline E. Sutton et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet’s disease
- (2012) María Carmen Cénit et al. HUMAN IMMUNOLOGY
- Levels of Circulating Th17 Cells and Regulatory T Cells in Ankylosing Spondylitis Patients with an Inadequate Response to Anti−TNF-α Therapy
- (2012) Li Xueyi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial
- (2012) Kim A. Papp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis
- (2012) Wei-Sheng Chen et al. Journal of the Chinese Medical Association
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- The gut microbiota in IBD
- (2012) Chaysavanh Manichanh et al. Nature Reviews Gastroenterology & Hepatology
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
- (2012) Raquel Celis et al. ARTHRITIS RESEARCH & THERAPY
- Interleukin-23: A key cytokine in inflammatory diseases
- (2011) Emilie Duvallet et al. ANNALS OF MEDICINE
- Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
- (2011) Troy Noordenbos et al. ARTHRITIS AND RHEUMATISM
- Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis
- (2011) Tony J. Kenna et al. ARTHRITIS AND RHEUMATISM
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Interleukin-23: as a drug target for autoimmune inflammatory diseases
- (2011) Chunlei Tang et al. IMMUNOLOGY
- IL-17 receptor and its functional significance in psoriatic arthritis
- (2011) Siba P. Raychaudhuri et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Autoimmunity's collateral damage: Gut microbiota strikes 'back'
- (2011) Daniel J Cua et al. NATURE MEDICINE
- Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
- (2011) Heiner Appel et al. ARTHRITIS RESEARCH & THERAPY
- The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
- (2010) M. Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- Role of Th17 cells in human autoimmune arthritis
- (2010) Jan Leipe et al. ARTHRITIS AND RHEUMATISM
- Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis
- (2010) Yang Mei et al. CLINICAL RHEUMATOLOGY
- Frequency and Phenotype of T Helper 17 Cells in Peripheral Blood and Synovial Fluid of Patients with Reactive Arthritis
- (2010) H. SHEN et al. JOURNAL OF RHEUMATOLOGY
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
- (2010) Amy Strange et al. NATURE GENETICS
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
- (2009) M Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
- (2009) L. Melis et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis
- (2009) Hui Shen et al. ARTHRITIS AND RHEUMATISM
- HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats
- (2009) Monica L. DeLay et al. ARTHRITIS AND RHEUMATISM
- Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis
- (2009) Francesco Ciccia et al. ARTHRITIS AND RHEUMATISM
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
- (2009) Caroline E. Sutton et al. IMMUNITY
- Interleukin-23/Th17 pathways and inflammatory bowel disease
- (2009) Clara Abraham et al. INFLAMMATORY BOWEL DISEASES
- Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
- (2009) Alice Gottlieb et al. LANCET
- Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis
- (2009) Xinwei Wang et al. RHEUMATOLOGY INTERNATIONAL
- Stepwise Development of MAIT Cells in Mouse and Human
- (2009) Emmanuel Martin et al. PLOS BIOLOGY
- The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
- (2009) Sarah L. Gaffen Current Rheumatology Reports
- Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides
- (2008) Camilla Jandus et al. ARTHRITIS AND RHEUMATISM
- γδ T cells: an important source of IL-17
- (2008) Christina L Roark et al. CURRENT OPINION IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now